mattkid76, what TIS could have done is what they said they were going to do and had planned to do.
IMO to change their CE Mark submission for the sake of a possible two months at the end of the sales process (in 16 month time, say 15%) is poor management and misleading. It does appear as though this is purely an excuse because IMO if the market is going to accept Vitrogro as we all hope, TIS may need the additional product anyway.
Just think if TIS had managed to obtain CE Mark approval already and started sales TIS might have been one of the few shining lights out there in today's market that would have drawn even more attention and possible believers.
Instead we have a declining SP and are grouped with other non-performers as TIS stutter through yet another important milestone. Similar issues regarding our potential partner last year and potentially same SP affect.
It is interesting that the new website does not let you see announcements from previous years.
All IMO and DYOR.
TIS Price at posting:
45.0¢ Sentiment: None Disclosure: Held
